Бектурсынов С.М. – канд. мед. наук,
Баишева С.А. – докт. мед. наук, профессор,
Турекеев Б.А. – докт. мед. наук Казахский научно-исследовательский институт онкологии и радиологии Талдыкорганский областной онкологический диспансер
СОВЕРШЕНСТВОВАННЫЙ МЕТОД ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ В СОЧЕТАНИИ С ХИМИОИММУНОТЕРАПИЕЙ
Own method of breast cancer surgery had been developed. As opposed to commonly accepted principle of starting treatment of hematoimmunological complications as they appear,
their prophylaxis with thymalinum was carried out in the course of basic treatment. General three-years survival rate of patients was on average 94,7%.
Own method of breast cancer surgery had been developed. As opposed to commonly accepted principle of starting treatment of hematoimmunological complications as they appear, their prophylaxis with thymalinum was carried out in the course of basic treatment. General three-years survival rate of patients was on average 94,7%.
СОВЕРШЕНСТВОВАННЫЙ МЕТОД ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ В СОЧЕТАНИИ С ХИМИОИММУНОТЕРАПИЕЙ
Own method of breast cancer surgery had been developed. As opposed to commonly accepted principle of starting treatment of hematoimmunological complications as they appear,
their prophylaxis with thymalinum was carried out in the course of basic treatment. General three-years survival rate of patients was on average 94,7%.
Own method of breast cancer surgery had been developed. As opposed to commonly accepted principle of starting treatment of hematoimmunological complications as they appear, their prophylaxis with thymalinum was carried out in the course of basic treatment. General three-years survival rate of patients was on average 94,7%.
СОВЕРШЕНСТВОВАННЫЙ МЕТОД ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ В СОЧЕТАНИИ С ХИМИОИММУНОТЕРАПИЕЙ
Own method of breast cancer surgery had been developed. As opposed to commonly accepted principle of starting treatment of hematoimmunological complications as they appear,
their prophylaxis with thymalinum was carried out in the course of basic treatment. General three-years survival rate of patients was on average 94,7%.
Own method of breast cancer surgery had been developed. As opposed to commonly accepted principle of starting treatment of hematoimmunological complications as they appear, their prophylaxis with thymalinum was carried out in the course of basic treatment. General three-years survival rate of patients was on average 94,7%.